Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA1 | P00915 | 2/20 | 0.50 |
| ▸ | CA2 | P00918 | 2/20 | 0.50 |
| ▸ | RXRA | P19793 | 1/20 | 0.50 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.47 |
| ▸ | CA12 | O43570 | 1/20 | 0.47 |
| ▸ | CA3 | P07451 | 1/20 | 0.47 |
| ▸ | PKM | P14618 | 1/20 | 0.47 |
| ▸ | CA4 | P22748 | 1/20 | 0.47 |
| ▸ | CA6 | P23280 | 1/20 | 0.47 |
| ▸ | CA5A | P35218 | 1/20 | 0.47 |
| ▸ | CA7 | P43166 | 1/20 | 0.47 |
| ▸ | CA9 | Q16790 | 1/20 | 0.47 |
| ▸ | CA14 | Q9ULX7 | 1/20 | 0.47 |
| ▸ | CA5B | Q9Y2D0 | 1/20 | 0.47 |
| ▸ | TPMT | P51580 | 2/20 | 0.45 |
| ▸ | CASR | P41180 | 1/20 | 0.44 |
| ▸ | PTGS2 | P35354 | 1/20 | 0.44 |
| ▸ | LMNA | P02545 | 2/20 | 0.44 |
| ▸ | CNR2 | P34972 | 1/20 | 0.43 |
| ▸ | PARP1 | P09874 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30197284 | 1.00 | CA1 (0.50) | CA1CA2RXRAKDM4ECA12 | |
| Hydrochloric Acid SCHEMBL3767130 | 0.98 | RXRA (0.49) | CA1CA2RXRAKDM4ECA12 | |
| 3,5-Dimethoxybenzoic Acid SCHEMBL503889 | 0.85 | RXRA (0.64) | CA1CA2RXRAKDM4ECA12 | |
| SCHEMBL39734 | 0.85 | CA1 (0.60) | CA1CA2RXRAKDM4ECA12 | |
| SCHEMBL3087859 | 0.84 | PARP1 (0.56) | CA1CA2PARP1ALDH1A1KMT2A | |
| Hydrochloric Acid SCHEMBL3361588 | 0.83 | CA1 (0.58) | CA1CA2RXRAKDM4ECA12 | |
| 3,5-Dimethoxybenzoic Acid SCHEMBL20592058 | 0.83 | RXRA (0.62) | CA1CA2RXRAKDM4ECA12 | |
| Hydrochloric Acid SCHEMBL19118500 | 0.83 | CA1 (0.58) | CA1CA2RXRAKDM4ECA12 | |
| 3,5-Dimethoxybenzoic Acid SCHEMBL5668197 | 0.83 | RXRA (0.62) | CA1CA2RXRAKDM4ECA12 | |
| SCHEMBL414382 | 0.82 | CA1 (0.52) | CA1CA2KDM4ECA12PKM |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 271 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-117800914-B | Anti-SARS-CoV-2 virus armstrong mutant inhibitor | 中国人民解放军海军军医大学 | 2026-05-19 | — | — | CN | claimed |
| WO-2025085689-A1 | EXTRACELLULAR SMALL MOLECULE ACTIVATORS TARGETING BESTROPHIN CHANNELS FOR DISEASE TREATMENT | THE TRUSTEES OF COLUMBIA UNIVERSITY IN THE CITY OF NEW YORK (US) | 2025-04-24 | — | — | WO | claimed |
| CN-106232216-B | Composite polyamide membrane post-treated with nitrous acid | 陶氏环球技术有限责任公司 | 2019-10-11 | — | — | CN | claimed |
| US-9943810-B2 | Composite polyamide membrane post-treated with nitrous acid | DOW GLOBAL TECHNOLOGIES LLC (US) | 2018-04-17 | — | — | US | claimed |
| US-20170203259-A1 | COMPOSITE POLYAMIDE MEMBRANE POST-TREATED WITH NITROUS ACID | THE DOW CHEMICAL COMPANY | 2017-07-20 | — | — | US | claimed |
| CN-106232216-A | Composite polyamide membrane post-treated with nitrous acid | 陶氏环球技术有限责任公司 | 2016-12-14 | — | — | CN | claimed |
| WO-2015175258-A1 | COMPOSITE POLYAMIDE MEMBRANE POST-TREATED WITH NITROUS ACID | DOW GLOBAL TECHNOLOGIES LLC (US) | 2015-11-19 | — | — | WO | claimed |
| CN-117800914-B | Anti-SARS-CoV-2 virus armstrong mutant inhibitor | 中国人民解放军海军军医大学 | 2026-05-19 | — | — | CN | disclosed |
| US-12391647-B2 | Benzamide compound and preparation method, use, and pharmaceutical composition thereof | INSTITUTE OF MATERIA MEDICA, CHINESE ACADEMY OF MEDICAL SCIENCES (CN) | 2025-08-19 | — | — | US | disclosed |
| WO-2025085689-A1 | EXTRACELLULAR SMALL MOLECULE ACTIVATORS TARGETING BESTROPHIN CHANNELS FOR DISEASE TREATMENT | THE TRUSTEES OF COLUMBIA UNIVERSITY IN THE CITY OF NEW YORK (US) | 2025-04-24 | — | — | WO | disclosed |
| CN-115335378-B | Monoacylglycerol lipase modulators | 詹森药业有限公司 | 2025-03-04 | — | — | CN | disclosed |
| CN-114796204-B | Application of ansa triene compounds in antiviral infection medicines and preparation method thereof | 中国人民解放军海军军医大学 | 2024-07-16 | — | — | CN | disclosed |
| US-20240228484-A1 | MONOACYLGLYCEROL LIPASE MODULATORS | JANSSEN PHARMACEUTICA NV (BE) | 2024-07-11 | — | — | US | disclosed |
| WO-2008094438-A1 | MACROLACTAMS BY ENGINEERED BIOSYNTHESIS | KOSAN BIOSCIENCES INCORPORATED (US) | 2008-08-07 | — | — | WO | disclosed |
| US-20070105890-A1 | Novel condensed imidazole derivative | DAINIPPON SUMITOMO PHARMA CO., LTD | 2007-05-10 | — | — | US | disclosed |
| EP-1690863-A1 | NOVEL CONDENSED IMIDAZOLE DERIVATIVE | Dainippon Sumitomo Pharma Co., Ltd. (JP) | 2006-08-16 | — | — | EP | disclosed |
| US-20040116654-A1 | Heterogeneous foldamers containing alpha, beta, and/or gamma-amino acids | NATIONAL SCIENCE FOUNDATION | 2004-06-17 | — | — | US | disclosed |
| WO-2004018644-A2 | HETEROGENEOUS FOLDAMERS CONTAINING α, β, AND/OR Ϝ-AMINO ACIDS | WISCONSIN ALUMNI RESEARCH FOUNDATION (US) | 2004-03-04 | — | — | WO | disclosed |
| US-6165998-A | Antifungal agents | SCRIPTGEN PHARMACEUTICALS, INC. (US) | 2000-12-26 | — | — | US | disclosed |
| WO-1999013714-A1 | ANTIFUNGAL AGENTS | SCRIPTGEN PHARMACEUTICALS, INC. (US) | 1999-03-25 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070105890-A1 | Novel condensed imidazole derivative | DPP4, DPP7, DPP3 | CA1 2706/4885CA2 1527/4885RXRA 2749/4885 |
| US-12391647-B2 | Benzamide compound and preparation method, use, and pharmaceutical composition thereof | JAK2, STAT3, STAT5A | CA1 1768/4885CA2 573/4885RXRA 2841/4885 |
| US-20240228484-A1 | MONOACYLGLYCEROL LIPASE MODULATORS | MGLL, LPL, PNLIP | CA1 2588/4885CA2 3102/4885RXRA 196/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.